immune response Archives

New research with lymph node biopsies showed that the immune response following the Pfizer vaccine lasts much longer than previously assumed. This publication is based on a research paper date June 29, 2021 in Nature. US researchers at Washington University School of Medicine in St. L

Read More

July 28, 2021

by Ray Schilling

0 Comment

active immune response, b cells producing antibodies, immune response, lymph node biopsies, monoclonal antibodies, pfizer vaccine, sars-cov-2 vaccine, specific antibodies, spike protein, vaccination

Notably, Oxford University completed a phase II clinical trial that showed that a new malaria vaccine is promising. Marketly, it had an efficacy of 77% in 450 children with an age of between 5 and 17 months. It is important to realize that clinicians conducted this clinical trial in A

Read More

May 19, 2021

by Ray Schilling

0 Comment

higher efficacy malaria vaccine, immune response, malaria deaths, malaria vaccine, malaria vaccine research team, phase III clinical trial, vaccinated children, vaccination, vaccine manufacturer, young children

Pfizer recently announced their vaccine is 90% effective, so I thought I explain how the Covid-19 vaccine works. There is a wide variety of RNA viruses The West Nile virus belongs there, so does the hepatitis A and C virus. Poliovirus, the Corona viruses (SARS, Covid-19 coronavirus),

Read More

December 09, 2020

by Ray Schilling

0 Comment

antibodies, covid-19 coronavirus, elderly patients, genetic engineering, immune response, immune system, mrna, rna vaccine, rna viruses, vaccine

Melanoma Survival Improved With The Immunomodulator Opdivo®

A new study presented at an American Cancer Research Conference in New Orleans has shown that melanoma survival improved with the immunomodulator Opdivo®. After 5 years of treatment with Opdivo® 34% of patients were alive, while only 16% of melanoma patients receiving conventional tre

Read More

January 11, 2017

by Ray Schilling

0 Comment

earlier stage melanoma, immune checkpoint inhibitors, immune response, immunomodulator, life expectancy, melanoma, melanoma patients, melanoma survival, opdivo, special proteins

Immune Response following the Pfizer Vaccine Lasts Much Longer

New Malaria Vaccine Is Promising

How the Covid-19 Vaccine Works

Melanoma Survival Improved With The Immunomodulator Opdivo®

NethealthBook.com

Certificates

A Survivor’s Guide to Successful Aging

Prostate Cancer Unmasked

Healing Gone Wrong – Healing Done Right

Medical Questions Answered